Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

Clinical trial NCT02016924 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02016924
Sponsor: Gilead Sciences
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acquired Immune Deficiency Syndrome (AIDS)HIV Infections

Start date: 2014-01-16
Primary completion: 2025-06-13
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.